Literature DB >> 6510458

Effect of praziquantel on human lymphocyte proliferation in vitro.

N Odum, T G Theander, I C Bygbjerg.   

Abstract

The antischistosomal drugs tartar emetic and niridazole exert immunosuppression both in vitro and in vivo. In the present study the influence of praziquantel (Biltricide), a potent schistosomicidal drug, on human lymphocyte proliferation in vitro was investigated. Praziquantel 80 micrograms/ml significantly reduced thymidine incorporation by human blood mononuclear cells stimulated with mitogens and antigens, whereas no effect could be detected in concentrations below 40 micrograms/ml. Thus, praziquantel, in concentrations as high as 30 times the peak serum concentration during therapy, has no suppressive effect on human lymphocyte proliferation in vitro.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6510458     DOI: 10.1007/bf00542166

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  The study of the immune responses in patients with uncomplicated urinary schistosomiasis.

Authors:  A M El-Hawey; K S Abdel-Wahab; M A Saber
Journal:  J Egypt Med Assoc       Date:  1978

2.  In vivo and in vitro experiments on the effects of praziquantel on Schistosoma mansoni. A light and electron microscopic study.

Authors:  H Mehlhorn; B Becker; P Andrews; H Thomas; J K Frenkel
Journal:  Arzneimittelforschung       Date:  1981

Review 3.  Praziquantel.

Authors:  P Andrews; H Thomas; R Pohlke; J Seubert
Journal:  Med Res Rev       Date:  1983 Apr-Jun       Impact factor: 12.944

4.  Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity.

Authors:  K S Warren; E O Domingo; R B Cowan
Journal:  Am J Pathol       Date:  1967-11       Impact factor: 4.307

5.  Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole.

Authors:  L T Webster; A E Butterworth; A A Mahmoud; E N Mngola; K S Warren
Journal:  N Engl J Med       Date:  1975-05-29       Impact factor: 91.245

6.  Observations on praziquantel against Schistosoma haematobium.

Authors:  J E McMahon
Journal:  Arzneimittelforschung       Date:  1981

7.  [Trial of praziquantel in the treatment of urinary schistosomiasis in Senegal].

Authors:  S Diallo; A Victorius; F Diouf; O Ndir; Y Dieng; I B Bah
Journal:  Arzneimittelforschung       Date:  1981

8.  The pathological effects of immunosuppression of Schistosoma mansoni-infected mice, with particular reference to survival and hepatotoxicity after thymectomy and treatment with antithymocyte serum, and treatment with hydrocortisone acetate.

Authors:  S Lucas; R Musallam; J Bain; O Hassounah; Q Bickle; M Doenhoff
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

9.  Preliminary trials with praziquantel in human infections due to Schistosoma mansoni.

Authors:  N Katz; R S Rocha; A Chaves
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

10.  Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. I. Effect of treatment on in vitro cellular responsiveness.

Authors:  I S Barsoum; F M Gamil; M A Al-Khafif; R M Ramzy; M A El Alamy; D G Colley
Journal:  Am J Trop Med Hyg       Date:  1982-11       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.